Previous close | 507.40 |
Open | 511.60 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 511.20 - 532.60 |
52-week range | 308.60 - 599.40 |
Volume | |
Avg. volume | 202,800 |
Market cap | 38.38B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 59.93 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.00 (0.79%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...